Efficacy and Safety of Danzhen

PHASE1UnknownINTERVENTIONAL
Enrollment

3,300

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2017

Conditions
Migraine
Interventions
DRUG

Danzhen

DRUG

Topiramate

Trial Locations (1)

710032

Xijing Hospital, Xi’an

Sponsors
All Listed Sponsors
collaborator

Ecion Pharmaceutical CO..LTD

UNKNOWN

lead

Xijing Hospital

OTHER

NCT02645370 - Efficacy and Safety of Danzhen | Biotech Hunter | Biotech Hunter